checkAd

    DGAP-Adhoc  156  0 Kommentare CompuGroup Medical SE & Co. KGaA acquires eMDs

    DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Mergers & Acquisitions
    CompuGroup Medical SE & Co. KGaA acquires eMDs

    23-Nov-2020 / 08:08 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    Today, CompuGroup Holding USA, Inc., a 100 % subsidiary of CompuGroup Medical SE & Co. KGaA ("Company"), and MDeverywhere Midco, Inc., USA, the sole indirect shareholder of eMDs, Inc., USA (jointly "eMDs"), have entered into an agreement regarding acquisition of 100 % issued and outstanding capital stock of eMDs. The competent corporate bodies of the Company have already approved the transaction.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu CompuGroup Medical!
    Long
    25,78€
    Basispreis
    0,25
    Ask
    × 11,16
    Hebel
    Short
    30,18€
    Basispreis
    0,26
    Ask
    × 10,73
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    eMDs' key products are Ambulatory Information Systems and outsourcing services for the accounting of medical services. CGM is thus strengthening its position in the USA significantly and, after the acquisition, will be the top 4 in the market for Ambulatory Information Systems in the USA based on the number of independent doctors' practices which are not part of a hospital.

    The transaction is structured as a reverse triangular merger under U.S. law. The consideration to be paid to the current shareholders of eMDs is based on an enterprise value of approx. USD 240 million (approx. EUR 203 million), which will be adjusted inter alia for amounts of cash, financial debt and net working capital (compared to a reference amount) as of the closing date. In the fiscal year 2019/2020 (ended 2020/03/31), eMDs generated revenues of approx. EUR 81 million and an EBITDA of approx. EUR 12 million with more than 60.000 healthcare providers.

    Closing of the transaction is expected by the end of 2020 and is in particular subject to approvals by the U.S. merger control and investment control authorities.


    23-Nov-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de


    Language: English
    Company: CompuGroup Medical SE & Co. KGaA
    Maria Trost 21
    56070 Koblenz
    Germany
    Phone: +49 (0)261 8000 7030
    Fax: +49 (0)261 8000 3200
    E-mail: investor@cgm.com
    Internet: www.cgm.com
    ISIN: DE000A288904
    WKN: A28890
    Indices: MDAX, TecDAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1149807

     
    End of Announcement DGAP News Service

    1149807  23-Nov-2020 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1149807&application_name=news&site_id=wallstreet

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-Adhoc CompuGroup Medical SE & Co. KGaA acquires eMDs DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Mergers & Acquisitions CompuGroup Medical SE & Co. KGaA acquires eMDs 23-Nov-2020 / 08:08 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No …

    Schreibe Deinen Kommentar

    Disclaimer